NEW YORK and SAN FRANCISCO, May 11 /PRNewswire/ -- Behrman Capital, a private investment firm focusing on emerging growth companies, today announced that Robert F. Byrnes has joined the firm as an operating partner. Mr. Byrnes, 53, has had a distinguished career as a health care executive in start-up, mid-size, and Fortune 100 companies covering a wide spectrum of the health care industry. As an operating partner at Behrman Capital, Mr. Byrnes will be involved in finding and evaluating potential acquisition candidates and developing new platforms in the health care services sector for the firm's continued expansion. He will also work with existing portfolio companies to add value and will act as a non-executive chairman or board member for new portfolio companies. "We are very pleased that someone of Bob Byrnes' outstanding experience and proven ability is joining our team," said Darryl G. Behrman, a Managing Partner of Behrman Capital. "Bob has had an extremely successful and diverse career, serving as business executive, consultant, entrepreneur, turnaround, and merger expert for both private and public companies. In particular, his experience ranges from successfully managing specialty drug, device, and health care service operations, to raising private funding for four start-up companies, three of which went public. Bob's varied skills, as well as his broad and deep knowledge of the health care industry and significant managerial experience, will be invaluable to us and our portfolio companies as we continue to grow our firm." In addition to his responsibilities at Behrman Capital, Mr. Byrnes will continue to serve as President and CEO of ROAN Inc., a consulting firm that provides strategic, operational and financial advisory services to small and medium size healthcare organizations. Prior to creating ROAN Inc. in 1997, Mr. Byrnes served as President and CEO of Matria Healthcare Inc., a specialty obstetrics and gynecological (OB/GYN) service organization. He successfully oversaw the creation of Matria -- which was born out of the March, 1996 merger of Healthdyne, Inc and Tokos Medical Corporation. Before merging Tokos with Healthdyne, Mr. Byrnes was Chairman and CEO of Tokos, which under his leadership grew from a start-up specialty OB/GYN device and service organization into the leading national provider of OB/GYN homecare services for high-risk, complicated pregnancies. Mr. Byrnes has also held senior management positions at Caremark, Inc., a start-up homecare company focusing on patients requiring infusion therapies and nutritional support; Genentech, Inc., a start-up company which was the first to develop, manufacture, and market biotech pharmaceuticals; and American Hospital Supply Corporation, a multinational healthcare company. He also worked for Abbot Laboratories, Eli Lilly and Co., and Osco Drugs during the early years of his career. Over the past sixteen years, Mr. Byrnes has had extensive board experience, serving as a member of fifteen different Boards of Directors for non-profit, public and private organizations. He has a B.S. in Pharmacy from Ferris State University in Big Rapids, Michigan, and an M.B.A. from Loyola University in Chicago. Behrman Capital invests in management buyouts of growth companies focused on the health care services, outsourced manufacturing, and information technology industries, as well as special situations. The firm also provides expansion capital to emerging growth companies, principally in the high technology and health care services industries. Based in New York City and San Francisco, Behrman Capital was founded in 1992 by Darryl G. and Grant G. Behrman. The firm currently has a combined capital base exceeding $640 million.
SOURCE Behrman Capital